{
    "code": "10000622",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000622",
    "time": "2017-12-22 03:27:36",
    "許可證字號": "衛署菌疫輸字第000622號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/06\/13",
    "發證日期": "89\/11\/17",
    "許可證種類": "菌　疫",
    "舊證字號": "02019306",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000062207",
    "中文品名": "宜保利血注射液１００００單位\/毫升",
    "英文品名": "EPREX INJECTION 10000 U\/ML",
    "適應症": "治療與慢性腎臟功能失調有關的貧血症或因此而需要輸血的患者、治療與癌症化學治療有關的貧血。",
    "劑型": "270注射劑",
    "包裝": "1ml (10000IU)小瓶裝 0.3ml (3000IU)、0.4ml (4000IU)、0.5ml (5000IU)、 0.6ml (6000IU)、0.7ml (7000IU)、0.8ml (8000IU)、 0.9ml (9000IU)、1.0ml (10000IU)注射針筒裝 100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "EPOETINALFA"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F430015000  CILAG AG.",
        "製造廠廠址": "HOCHSTRASSE 201 CH-8200 SCHAFFHAUSEN SWITZERLAND",
        "製造廠公司地址": "HOCHSTRASSE 201,CH-8205 SCHAFFHAUSEN ,SWITZERLAND"
    },
    "CCC號列": "30049020007 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparationsof gennetic recombinants",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1600001200",
            "成分名稱": "EPOETIN ALFA",
            "含量描述": "",
            "含量": "84.0000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "EPREX 1000 2000 4000 8000 10000-104-09-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000622&Seq=042&Type=9"
        }
    ]
}